News

Jill M. Kramer, DDS, PhD, associate professor in the Department of Oral Biology at the University at Buffalo School of Dental ...
Venus Williams is back on the professional tennis tour at age 45 and will be returning to the U.S. Open next week for her ...
The Chicago Stars have named former Norway women's national team coach Martin Sjögren as the National Women's Soccer League club’s new head coach. Sjögren will join the Stars starting with the 2026 ...
The China-based phase 3 trial of telitacicept in primary Sjögren's syndrome (pSS) met its primary endpoint, which focused on ...
Ianalumab is a fully human monoclonal antibody designed to deplete B cells via antibody-dependent cellular toxicity and inhibit BAFF-R-mediated signals of B cell function and survival.
Novartis now sees the potential for the drug to become the first and only targeted treatment approved for patients with the ...
The drug, ianalumab, met its objectives in two Phase 3 studies in Sjögren’s syndrome, boosting the outlook of a ...
Novartis may have abandoned one Sjögren's syndrome asset this year, but it looks like the drugmaker has a winner on its hands ...
Adults with Sjögren’s disease complicated by a subtype of cutaneous vasculitis are more likely to develop non-Hodgkin’s ...